You are here

biosimilars

Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat

BioPharma Dive

Mon, 10/18/21 - 10:55 pm

Boehringer Ingelheim

interchangeable biosimilars

Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year

Fierce Pharma

Fri, 10/8/21 - 10:32 am

Physicians hesitant to switch patients from biologics to biosimilar drugs, report finds

Beckers Hospital Review

Mon, 09/27/21 - 10:55 am

Biosimilar drugs gain ground in U.S., but concerns linger about when patients can switch

Stat

Tue, 09/21/21 - 10:45 am

FDA finalizes more Q&As on biosimilar development

RAPS.org

Mon, 09/20/21 - 11:03 pm

drug development

FDA approves first biosimilar to top-selling eye drug Lucentis

BioPharma Dive

Mon, 09/20/21 - 10:55 pm

age-related macular degeneration

Samsung Bioepis

Sandoz in oncology biosimilar deal with China’s Bio-Thera

Biopharma Reporter

Wed, 09/8/21 - 11:15 am

Bio-Thera Solutions

Pharmacist-driven biosimilar substitution saves money

GaBI

Sat, 08/28/21 - 09:08 pm

Biosimilars versus biologics: Is marketing madness on the way as biosimilar approvals balloon?

Fierce Pharma

Tue, 08/17/21 - 10:13 am

J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report

Fierce Pharma

Thu, 08/12/21 - 11:04 pm

PhRMA calls for FDA to address unique needs of biosimilar review program

Biopharma Reporter

Mon, 08/9/21 - 10:59 am

capacity planning adjustment

How This Historic FDA Approval Benefits Viatris

Motley Fool

Wed, 08/4/21 - 10:57 am

interchangeable biosimilars

FDA approves first interchangeable biosimilar

Biopharma Reporter

Thu, 07/29/21 - 11:19 am

interchangeable biosimilars

Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms

Fierce Pharma

Mon, 07/26/21 - 10:14 pm

Cost-cutting generics and biosimilars stuck in legal limbo

MedCity News

Thu, 07/22/21 - 10:58 am

Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst

Fierce Pharma

Tue, 07/13/21 - 11:02 am

AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira

Endpoints

Mon, 05/24/21 - 11:30 pm

Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'

Fierce Pharma

Tue, 05/11/21 - 10:23 pm

Another 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025

Fierce Pharma

Fri, 05/7/21 - 10:39 am

autoimmune disease

Merck spinoff Organon to begin trading in June

Seeking Alpha

Tue, 05/4/21 - 10:47 am

Pages